Insights

Insights

Filter by:
Governing Laws
Sector
Sub-sector
Service Venture capital
Sub-service
Hot Topics
Safe deposit boxes
Banking & finance

Silicon Valley Bank – how big will the fallout be in the financial markets?

15 March 2023
Briefing

by David de Ferrars

Click here to find out more
Safe deposit boxes
Banking & finance

HSBC's acquisition of Silicon Valley Bank UK

15 March 2023
Briefing

by Gabriel Estevez and Angus Miln

Click here to find out more
View from below of forest trees
Environmental, social & governance (ESG)

Value of food-tech and ag-tech industries

22 February 2023

by multiple authors

Click here to find out more
Interface - Femtech and issues around digital health products

'Femtech' funding – challenges and opportunities

Alexandra Richardson and Phil Shepherd look at the issues facing femtech funding and at the potential for growth.

29 October 2021
Quick read

by Alexandra Richardson and Philip Shepherd

3 of 5 Insights

Click here to find out more
Interface - Tech M&A

“SPAC” - Special Purpose Acquisition Company

21 September 2021
Briefing

by Alexander R. Roth, M.Jur. (Oxford)

3 of 7 Insights

Click here to find out more
Corporate/M&A & capital markets

US and UK national security and investment – a joint discussion with CFIUS and BEIS

11 May 2021

by multiple authors

Click here to find out more
dubai-horizon
Venture capital

Venture capital in the Middle East – what to expect in 2021

26 April 2021
Quick read
Click here to find out more
Technology, media & communications

CSR and Law

11 February 2021

by multiple authors

Click here to find out more
Interface - CSR and Law

ESG and Investments - Return on Sustainability

10 February 2021
Briefing

by Dr. Jens Wolf

6 of 10 Insights

Click here to find out more
Patterned pills
Life sciences & healthcare

Edison Open House Global Healthcare 2021 – key takeaways from our panel

4 February 2021
Quick read

by multiple authors

Click here to find out more
scientist-with-molecule-models
Life sciences & healthcare

Impact of COVID-19 on venture-backed biotech companies – Part 2: Investment and cash flow

23 June 2020
IN-DEPTH ANALYSIS

by Adrian Toutoungi and Josef Fuss

Click here to find out more
scientist-with-vials
Life sciences & healthcare

Impact of COVID-19 on venture-backed biotech companies – Part 1: Operational issues

22 June 2020
IN-DEPTH ANALYSIS

by Adrian Toutoungi and Josef Fuss

Click here to find out more